Introduction {#section1-2333794X17744141}
============

The best indicator of vitamin D status is the serum 25-hydroxyvitamin D \[25(OH)D\] concentration.^[@bibr1-2333794X17744141]^ The Institute of Medicine defines vitamin D deficiency as serum 25(OH)D level of less than 20 ng/mL.^[@bibr1-2333794X17744141],[@bibr2-2333794X17744141]^ By this definition, the prevalence of vitamin D deficiency in a cross-sectional study of healthy urban adolescents in Boston, Massachusetts, was 42%.^[@bibr3-2333794X17744141]^ The authors concluded that vitamin D deficiency was present in many US adolescents, with prevalence being highest in African American teenagers and during winter, although the problem seems to be common across sex, season, and ethnicity.^[@bibr3-2333794X17744141]^ In the 2001 to 2006 National Health and Nutrition Examination Survey, the prevalence of vitamin D deficiency in healthy weight US adolescents and children was 21%. The prevalence dramatically increased to 29%, 34%, and 49%, respectively, in overweight, obese, and severely obese children and adolescents.^[@bibr4-2333794X17744141]^

The primary role of vitamin D is the mineralization of bone by regulating osteoblast activity and facilitating the absorption of calcium and phosphorus from the intestines and calcium from the kidneys via its active metabolite 1,25-dihydroxyvitamin D.^[@bibr5-2333794X17744141],[@bibr6-2333794X17744141]^ However, many studies have shown an association between vitamin D deficiency and chronic diseases including cardiovascular disease and its risk factors including dyslipidemia.^[@bibr5-2333794X17744141][@bibr6-2333794X17744141][@bibr7-2333794X17744141][@bibr8-2333794X17744141]-[@bibr9-2333794X17744141]^ In a nationally representative sample of children aged 1 to 21 years, in the National Health and Nutrition Examination Survey of 2001 to 2004, the authors concluded that vitamin D deficiency is common in the general US pediatric population and is associated with adverse cardiovascular risks.^[@bibr10-2333794X17744141]^ In a cross-sectional study of children aged 1 to 5 years from Canada, 25(OH)D levels were inversely associated with circulating lipids in early childhood, suggesting that vitamin D exposure in early life may be a modifiable risk for cardiovascular disease.^[@bibr9-2333794X17744141]^ In African American adolescents residing in the Midwestern United States, 25(OH)D levels were inversely correlated to TC (total cholesterol) and non-HDL-C (high-density lipoprotein cholesterol) levels.^[@bibr11-2333794X17744141]^

From the studies to date, it is clear that vitamin D deficiency is prevalent in US adolescents and is highly prevalent in minority and obese populations, and it may be associated with elevated lipid panels. However, there are no studies to date on the association between vitamin D deficiency, obesity, and lipid levels in Hispanic American adolescents. The purpose of the present study is to determine the relationship of vitamin D deficiency with body mass index (BMI) and lipid levels in otherwise healthy Hispanic American adolescents.

Subjects and Methods {#section2-2333794X17744141}
====================

A retrospective chart review of data collected from February 2016 to August 2017 was conducted at a pediatric clinic in Huntington Beach, California. From an initial 264 adolescents aged 13 to 19 years presenting for routine physical examinations, 238 were Hispanic. None were taking vitamin D supplementation. Four were excluded for chronic medical illnesses (specifically diabetes and hypertension), resulting in a final sample of 234 healthy Hispanic adolescents.

As part of routine physical examinations all subjects had BMI and vital signs recorded. Fasting blood sugar (FBS), 25(OH)D level, and a standard lipid panel were drawn. The standard lipid panel reports TC, low-density lipoprotein (LDL), HDL, triglycerides (TG), and TC/HDL ratio.

In this study, vitamin D deficiency is defined as a 25(OH)D level \<20 ng/mL, and vitamin D adequacy is defined as a 25(OH)D level of ≥20 ng/mL, according to Institute of Medicine parameters.^[@bibr1-2333794X17744141],[@bibr2-2333794X17744141]^ Dyslipidemia in adolescents is defined as TC ≥ 170 mg/dL, LDL ≥ 110 mg/dL, and TG ≥ 90 mg/dL, either individually or in combination, according to the guidelines from the National Institutes of Health and the National Cholesterol Education Program.^[@bibr12-2333794X17744141]^ BMI is defined as weight in kilograms/height in meters squared. Per Centers for Disease Control and Prevention guidelines, BMI \< 5% is underweight, 5% to 84% is healthy weight, 85% to 94% is overweight, and 95% or higher is obese.^[@bibr13-2333794X17744141]^

SPSS 24 and Epi Info 7 were used in the analyses. Chi-square test of association was applied to binary vitamin D status and BMI percentile groups. ANOVA of vitamin D levels and BMI percentile was performed. Comparison of means for lipid tests, blood sugar, and blood pressure was done by *t* test according to vitamin D status, and further analyzed according to BMI percentile. Pearson's correlation coefficient was determined for key study variables. Linear regression of the vitamin D status and BMI was done for each lipid test with significant correlation to vitamin D. Statistical significance was set at a *P* ≤ .05.

Results {#section3-2333794X17744141}
=======

The final sample of 234 Hispanic American adolescents consisted of 111 females (47.4%) and 123 males (52.6%). The mean sample age was 16 years. The 25(OH)D levels ranged from 6.7 ng/mL to 58 ng/mL, with a sample mean of 24.4 ng/mL. Of the total sample, 27.8% (n = 65) were vitamin D deficient and 72.2% (n = 169) were vitamin D adequate. A summary of sample characteristics related to sex, BMI, and vitamin D status is presented in [Table 1](#table1-2333794X17744141){ref-type="table"}.

###### 

Summary Description of Sample.

![](10.1177_2333794X17744141-table1)

                                             Female (n = 111)   Male (n = 123)   Total (N = 234)
  ------------------------------------------ ------------------ ---------------- -----------------
  BMI groups, n (%)                                                              
  Under/healthy weight (BMI \< 85%)          50 (45 %)          54 (43.9%)       104 (44.4%)
  Overweight/obese (BMI ≥ 85%)               61 (55%)           69 (56.1%)       130 (55.6%)
  Vitamin D status, n (%)                                                        
  Vitamin D deficient, 25(OH)D \< 20 ng/mL   40 (36%)           25 (20.3%)       65 (27.8%)
  Vitamin D adequate, 25(OH)D ≥ 20 ng/mL     71 (64%)           98 (79.7%)       169 (72.2%)

Abbreviations: BMI, body mass index; 25(OH)D, serum 25-hydroxyvitamin D.

Of the 65 subjects who were vitamin D deficient, 44 (67.7%) were overweight or obese compared with 21 (32.3%) who were healthy or underweight. This difference was significant, odds ratio = 2.02, 95% confidence interval = 1.11-3.69, χ^2^ = 5.37, *P* = .021, indicating that the odds of overweight and obese subjects to be vitamin D deficient was twice that of normal and underweight subjects. The mean vitamin D level in the overweight and obese subjects combined was 23.1 ± 6.6, and in the underweight and healthy weight subjects combined it was 26.1 ± 7.8 (*t* = −3.11, degrees of freedom \[df\] = 232, *P* = .002). In [Table 2](#table2-2333794X17744141){ref-type="table"}, ANOVA demonstrates the significant difference in mean vitamin D levels according to BMI percentile category (*F* = 3.64, df = 3, *P* = .014).

###### 

One-Way ANOVA of BMI Percentile and Vitamin D Level.

![](10.1177_2333794X17744141-table2)

  BMI % Category                  Total (N = 234)   Mean Vitamin D, ng/mL   Standard Deviation
  ------------------------------- ----------------- ----------------------- --------------------
  Underweight; BMI \< 5%          5                 26.5                    5.8
  Healthy weight; BMI 5% to 84%   99                26                      7.9
  Overweight; BMI 85% to 94%      55                24                      6.6
  Obese; BMI 95% to \>99%         75                22.5                    6.5

Abbreviation: BMI, body mass index.

A comparison of lipid means for those with vitamin D deficiency compared with those with adequate vitamin D in the sample as a whole shows significant differences in TC (160 ± 28.5 vs 147.1 ± 26.22, *P* = .0012), LDL (87.2 ± 24 vs 77.6 ± 21.8, *P* = .0067), and TG (127 ± 88.2 vs 84.8 ± 42.5, *P* = .000). However, given that a large percentage of the sample is overweight or obese, a factor known to influence vitamin D levels, the analyses skew to that portion. It is more accurate and meaningful to separate the underweight and healthy weight subjects from the overweight and obese subjects to discern the true effect of vitamin D on lipid levels. This is done with independent samples *t* tests in [Tables 3](#table3-2333794X17744141){ref-type="table"} and [4](#table4-2333794X17744141){ref-type="table"}, demonstrating that there is a significant influence of vitamin D deficiency on lipid levels in the overweight and obese subjects, but not in the underweight and healthy weight subjects.

###### 

Overweight and Obese Subjects, BMI 85% to \>99%; Means of Lipid Panel Levels, FBS, and BP by Vitamin D Status.

![](10.1177_2333794X17744141-table3)

                       Vitamin D Deficient (n = 44), Mean ± SD   Vitamin D Adequate; (n = 86), Mean ± SD   *t*        *P* ^[a](#table-fn4-2333794X17744141){ref-type="table-fn"}^
  -------------------- ----------------------------------------- ----------------------------------------- ---------- -------------------------------------------------------------
  Lipid panel                                                                                                         
   Total Cholesterol   165 ± 28.56                               145.67 ± 27.52                            **3.74**   **.0003**
   LDL                 92.65 ± 25.67                             80.84 ± 21.41                             **2.74**   **.007**
   Triglycerides       148.9 ± 97.1                              90.6 ± 40.74                              **4.82**   **.0000**
   HDL                 45.67 ± 11.34                             46.58 ± 11.12                             −0.44      .661
   TC/HDL              3.83 ± 1.11                               3.24 ± 0.73                               **3.60**   **.0005**
  Other tests                                                                                                         
   FBS                 82.61 ± 14.88                             83.88 ± 10.78                             −0.55      .5803
   Systolic BP         117.41 ± 14.1                             116.98 ± 14                               0.17       .8683

Abbreviations: LDL, low-density lipoprotein; HDL, high-density lipoprotein; TC, total cholesterol; FBS, fasting blood sugar; BP, blood pressure.

Significant *P* values are bolded.

###### 

Under and Healthy Weight Subjects, BMI \<5% to 84%; Means of Lipid Panel Levels, FBS, and BP by Vitamin D Status.

![](10.1177_2333794X17744141-table4)

                       Vitamin D Deficient (n = 21), Mean ± SD   Vitamin D Adequate, (n = 83), Mean ± SD   *t*     *P*
  -------------------- ----------------------------------------- ----------------------------------------- ------- -------
  Lipid panel                                                                                                      
   Total cholesterol   149.48 ± 25.94                            148.55 ± 24.88                            0.15    .8805
   LDL                 76.29 ± 15.83                             74.23 ± 21.88                             0.40    .6865
   Triglycerides       81.1 ± 36.88                              78.8 ± 43.71                              0.22    .8256
   HDL                 58.05 ± 15.32                             57.67 ± 13.35                             0.11    .915
   TC/HDL              2.73 ± 0.56                               2.67 ± 0.67                               0.36    .7186
  Other tests                                                                                                      
   FBS                 83.33 ± 5.75                              83.77 ± 10.63                             −0.18   .856
   Systolic BP         108.95 ± 14.04                            107.6 ± 11.82                             0.45    .6532

Abbreviations: LDL, low-density lipoprotein; HDL, high-density lipoprotein; TC, total cholesterol; FBS, fasting blood sugar; BP, blood pressure.

The correlation of key study variables, vitamin D, and BMI, along with the lipid panel tests, is presented in [Table 5](#table5-2333794X17744141){ref-type="table"}.

###### 

Correlation Matrix: Vitamin D, BMI, and Lipid Tests^[a](#table-fn7-2333794X17744141){ref-type="table-fn"}^.

![](10.1177_2333794X17744141-table5)

                                            Vitamin D                                                       BMI                                                             Total Cholesterol                                               LDL                                                            Triglycerides
  ------------------- --------------------- --------------------------------------------------------------- --------------------------------------------------------------- --------------------------------------------------------------- -------------------------------------------------------------- ---------------------------------------------------------------
  Vitamin D           Pearson correlation   1                                                               −.132[\*](#table-fn8-2333794X17744141){ref-type="table-fn"}     −.198[\*\*](#table-fn8-2333794X17744141){ref-type="table-fn"}   −.168[\*](#table-fn8-2333794X17744141){ref-type="table-fn"}    −.301[\*\*](#table-fn8-2333794X17744141){ref-type="table-fn"}
  *P*                                       **.043**                                                        **.002**                                                        **.010**                                                        **.000**                                                       
  BMI                 Pearson correlation   −.132[\*](#table-fn8-2333794X17744141){ref-type="table-fn"}     1                                                               .086                                                            .183[\*\*](#table-fn8-2333794X17744141){ref-type="table-fn"}   .183[\*\*](#table-fn8-2333794X17744141){ref-type="table-fn"}
  *P*                 **.043**                                                                              **.188**                                                        **.005**                                                        **.005**                                                       
  Total cholesterol   Pearson correlation   −.198[\*\*](#table-fn8-2333794X17744141){ref-type="table-fn"}   .086                                                            1                                                               .834[\*\*](#table-fn8-2333794X17744141){ref-type="table-fn"}   .429[\*\*](#table-fn8-2333794X17744141){ref-type="table-fn"}
  *P*                 .**002**              .188                                                                                                                            **.000**                                                        **.000**                                                       
  LDL                 Pearson correlation   −.168[\*](#table-fn8-2333794X17744141){ref-type="table-fn"}     .183[\*\*](#table-fn8-2333794X17744141){ref-type="table-fn"}    .834[\*\*](#table-fn8-2333794X17744141){ref-type="table-fn"}    1                                                              .314[\*\*](#table-fn8-2333794X17744141){ref-type="table-fn"}
  *P*                 **.010**              **.005**                                                        **.000**                                                                                                                        **.000**                                                       
  Triglycerides       Pearson correlation   .301[\*\*](#table-fn8-2333794X17744141){ref-type="table-fn"}    .183[\*\*](#table-fn8-2333794X17744141){ref-type="table-fn"}    .429[\*\*](#table-fn8-2333794X17744141){ref-type="table-fn"}    .314[\*\*](#table-fn8-2333794X17744141){ref-type="table-fn"}   1
  *P*                 .000                  .005                                                            .000                                                            .000                                                                                                                           
  HDL                 Pearson correlation   .069                                                            −.252[\*\*](#table-fn8-2333794X17744141){ref-type="table-fn"}   .231[\*\*](#table-fn8-2333794X17744141){ref-type="table-fn"}    −.125                                                          −.362[\*\*](#table-fn8-2333794X17744141){ref-type="table-fn"}
  *P*                 .296                  **.000**                                                        **.000**                                                        .056                                                            **.000**                                                       

Abbreviations: BMI, body mass index; LDL, low-density lipoprotein; HDL, high-density lipoprotein.

N = 234. Two-tailed significance, significant *P* values are bolded.

Correlation significant at the .05 level. \*\*Correlation significant at the .01 level.

As expected, vitamin D is significantly, negatively correlated with BMI, TC, LDL, and TG. BMI is significantly, positively correlated with LDL and TG. Most of the lipids are significantly, positively correlated with each other, with the exception of HDL and LDL, which has a modest negative correlation. HDL is significantly, negatively correlated with BMI, TC, and TG.

To further probe the respective influence of vitamin D and BMI on lipid levels, simultaneous linear regression of the 2 variables was performed for each of the lipid tests significantly correlated to vitamin D: TC, LDL, and TG. The results are shown in [Table 6](#table6-2333794X17744141){ref-type="table"}.

###### 

Linear Regression of Vitamin D and BMI With Lipid Panel^a^.

![](10.1177_2333794X17744141-table6)

  Lipid:          Total Cholesterol   LDL      Triglycerides                                                                                                                  
  --------------- ------------------- -------- ------------------------------------------------------------------ -------------- -------- ----------- --------------- ------- ------------
  Vitamin D       −0.72 (0.25)        8.57     **.0038[\*](#table-fn10-2333794X17744141){ref-type="table-fn"}**   −0.463 (0.2)   5.18     **.0238**   −2.39 (0.53)    20.2    **.00001**
  BMI             6.6 (7.01)          0.89     .3473                                                              14.75 (5.8)    6.46     **.0117**   35.37 (15.18)   5.43    **.0207**
  Constant        163.14 (8.75)       347.35   .0000                                                              80.24 (7.25)   122.68   .0000       127.65          45.35   .00000
  *R* ^2^         0.04                0.05     0.11                                                                                                                           
  *F* statistic   5.19                6.65     14.45                                                                                                                          

Abbreviations: BMI, body mass index; LDL, low-density lipoprotein; SE, standard error.

Significant *P* values are bolded.

The regression analyses shown in [Table 6](#table6-2333794X17744141){ref-type="table"} indicate that vitamin D is statistically significant in predicting TC while BMI is not. Both vitamin D and BMI are significant in predicting LDL. Both vitamin D and BMI are significant predictors of TG; however, the influence of vitamin D is stronger than that of BMI. The negative, significant correlations between vitamin D and TC, LDL, and TG identified in the [Table 5](#table5-2333794X17744141){ref-type="table"} correlation matrix are confirmed. The *R*^2^ (correlation coefficient) is relatively small for the panel of regressions as the independent cholesterol tests influence each other.

Discussion {#section4-2333794X17744141}
==========

Overweight and obese adolescents comprised 55.6% of the study sample, and 33.9% of them were vitamin D deficient. The overweight or obese subjects in this sample were twice as likely to be vitamin D deficient as the underweight or healthy weight subjects. As shown in [Table 2](#table2-2333794X17744141){ref-type="table"}, higher BMI levels were associated with lower vitamin D levels. Obesity is recognized to be associated with vitamin D deficiency as adipose tissue sequesters 25(OH)D, resulting in an inverse relationship between vitamin D and BMI.^[@bibr5-2333794X17744141],[@bibr14-2333794X17744141][@bibr15-2333794X17744141][@bibr16-2333794X17744141]-[@bibr17-2333794X17744141]^ Therefore, our results are in agreement with previous researchers who concluded that vitamin D deficiency is more prevalent in those who are obese.

In the study sample as a whole, the means of TC, LDL, TC/HDL ratio, and TG in those with vitamin D deficiency and elevated lipid panels were significantly higher compared with those with adequate vitamin D. However, these results reflect the large percentage of overweight and obese subjects in the sample. Furthermore, analysis according to BMI percentile shows that within the overweight or obese group the lipid panels of those with vitamin D deficiency were significantly higher compared with those with adequate vitamin D levels ([Table 3](#table3-2333794X17744141){ref-type="table"}). Notably, mean TG was in the dyslipidemic range as it was greater than 90 mg/dL (according to National Institute of Health/National Cholesterol Education Program parameters) in the overweight or obese vitamin D deficient group. In the healthy/underweight group, there were no statistically significant differences in any lipid tests between those with vitamin D deficiency and those with vitamin D adequacy ([Table 4](#table4-2333794X17744141){ref-type="table"}). In [Table 6](#table6-2333794X17744141){ref-type="table"}, regression analysis of the key variables, vitamin D and BMI, demonstrates that vitamin D level has a significant predictive effect on TC, LDL, and TG. The relationship to vitamin D is inverse, that is, lower vitamin D is associated with higher TC, LDL, and TG. BMI is also positively related to LDL and TG; however, the influence of BMI on TG is weaker than that of vitamin D. Additional comparison of means for fasting blood sugar and systolic blood pressure revealed no significant differences between those with vitamin D deficiency or adequacy in either BMI group ([Tables 3](#table3-2333794X17744141){ref-type="table"} and [4](#table4-2333794X17744141){ref-type="table"}).

A number of factors influence the blood level of vitamin D in humans. Diet, exposure to sunlight, vitamin D supplementation, and gastrointestinal, hepatic, and renal diseases are some of the well-documented factors.^[@bibr5-2333794X17744141]^ In addition, lower 25(OH)D levels have been associated with older age, winter season, higher BMI, black race/ethnicity, and female gender.^[@bibr18-2333794X17744141][@bibr19-2333794X17744141][@bibr20-2333794X17744141]-[@bibr21-2333794X17744141]^ Some of these confounding factors were controlled by including only healthy Hispanic adolescents living in Southern California in the study. The higher prevalence of vitamin D deficiency in female Hispanic adolescents compared with male Hispanics (36% and 20.3%, respectively, in this study) is in accordance with data from other epidemiological studies where females were noted to have a higher prevalence of vitamin D deficiency.^[@bibr19-2333794X17744141][@bibr20-2333794X17744141]-[@bibr21-2333794X17744141]^

In a systematic review of the literature for the US Preventive Services Task Force, Lozano et al reported that there have been no randomized controlled studies relevant to selective or universal screening for multifactorial dyslipidemia in children and adolescents.^[@bibr22-2333794X17744141]^ The elevated lipid panels and dyslipidemic TG in overweight or obese Hispanic adolescents associated with vitamin D deficiency in our study indicates a need for lipid screening in this population. The clinical implications and possibility of future cardiovascular risk needs to be ascertained by longitudinal studies.

This study did not include assessment of specific dietary intake, outdoor sun exposure, and family history of hyperlipidemia, nor does it include data analysis by season. The study was limited to Hispanic adolescents in Southern California, and the conclusions may not be applicable to other ethnic groups and to all healthy adolescents in the United States.

We conclude that vitamin D deficiency is prevalent in healthy Hispanic American adolescents and highly prevalent in those who are overweight or obese. Vitamin D deficiency is associated with higher mean TC, LDL, and TG in overweight or obese Hispanic adolescents when compared with those with adequate vitamin D. Although both BMI and vitamin D influence lipid levels, in regression analysis with TC, vitamin D enters the model at a statistically significant level while BMI does not. Vitamin D deficiency is also significantly predictive of higher mean LDL and TG along with BMI, but with a stronger correlation to TG than BMI. Vitamin D deficiency was associated with dyslipidemic TG levels in the overweight or obese adolescents. There was no significant difference in lipid levels related to vitamin D level in the underweight/healthy weight adolescents. These findings suggest a need for future research on the clinical implications of vitamin D deficiency and elevated lipid panels in overweight or obese Hispanic American adolescents, as well as appropriate clinical monitoring and intervention.
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